Andrew Eckstein is a Managing Director at BRG and has fourteen years of finance and accounting experience, over the last eleven years focusing on buy- and sell-side due diligence transactions in the middle market (up to $1 billion).
He specializes in quality of revenue analyses, proof of cash assistance, cash to accrual conversion, and working capital projections/negotiations.
Mr. Eckstein has averaged more than forty deals a year, and his experience includes a portfolio of transactions in each industry. Within healthcare, his recent transactions include leading deal teams in the following subsectors: dermatology, eye care, dental, pain management, home health, home infusion, acute and urgent care facilities, behavioral health, medical supplies, nurse staffing, and physical and speech therapy. His exposure to a wide range of industries allows him to bring unique perspectives on deal issues that may arise.
Areas of Expertise
Services
Education
University of Michigan
MS, Accounting, 2004
BS, Business Administration, 2003
Recognition
Eighth Annual Emerging Leader Award, The M&A Advisor (2017)